Labiotech.eu

In Depth 22 Jul 2020

Artificial Intelligence: A Superpower in the Fight Against Covid-19

The rapid spread of Covid-19 around the world has left drug developers with limited time to identify drug candidates to fight the virus. Amid this crisis, artificial intelligence has proven its value as a tool to make drug discovery faster and cost-effective. Drug discovery is an expensive, long-winded process. Taking a drug from discovery to […]

July 22, 2020 - 8 minutesmins - By David Kirk

News and Trends 21 Jul 2020

Global €870M Fund Launched to Address Antimicrobial Resistance

A global collaboration including the pharmaceutical industry and public funders such as the European Investment Bank has committed to investing €870M ($1B) in tackling the growing crisis of antibiotic-resistant superbugs. So far, over 20 pharmaceutical companies globally have contributed to the fund, called the AMR Action Fund. They are joined by other organizations such as […]

July 21, 2020 - 3 minutesmins - By Manuela Callari

News and Trends 17 Jul 2020

Russian Hackers Launch Cyber Attack on Covid-19 Vaccine Developers

The National Cyber Security Centre (NCSC) in the UK stated this week that several organizations involved in Covid-19 vaccine development in the UK, US, and Canada have been targeted in a cyber attack by a Russian hacking group known as APT29. The NCSC says that APT29, also known as ‘the Dukes’ or ‘Cozy Bear,’ is […]

July 17, 2020 - 3 minutesmins - By Helen Albert

News and Trends 17 Jul 2020

Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment

Unfazed by the financial turmoil caused by the Covid-19 pandemic, the Edinburgh-based firm Macomics and University of Cambridge spinout Spirea have each closed seed rounds this week to finance the development of novel cancer immunotherapies and more precise forms of chemotherapy. Macomics bagged €3.5M (£3.2M) in seed funding from the transatlantic VC firm Epidarex Capital […]

July 17, 2020 - 3 minutesmins - By Kostas Vavitsas

diabetic foot ulcer wound healing reapplix

News and Trends 17 Jul 2020

Danish Wound Healing Biotech Raises €20M to Accelerate US Rollout

Reapplix, a Danish biotech focusing on developing wound healing technology, has raised €19.8M in equity funding to commercialize a treatment for diabetic foot ulcers in the US. The company also announced it has received Medicare reimbursement instructions that it will receive an average of €1,420 ($1,623) for each patient in the US that receives its […]

July 17, 2020 - 3 minutesmins - By Helen Albert

News and Trends 16 Jul 2020

European Biotech Stocks Shine Amid 2020 Market Slump

As the Covid-19 pandemic leads us to the worst financial crisis in decades, normally volatile biotech stocks are outperforming most other sectors of the economy. Experts say this trend is likely to continue. Financial markets are in flux and according to a recent study by the Boston Consulting Group, the global economic slump caused by […]

July 16, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 14 Jul 2020

Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments

UK-based biopharmaceutical Amryt Pharma has listed on the Nasdaq Stock Market in a move to increase its US presence as it commercializes treatments for rare diseases such as the skin condition epidermolysis bullosa. The company did not raise any extra capital by releasing new shares in this debut, as is typical for most listings. But it […]

July 14, 2020 - 3 minutesmins - By Victor Kotsev

varmx blood thinners clot eartern brown snake

News and Trends 14 Jul 2020

€32M Series B to Fund Bleeding Medication Inspired by Snake Venom

The Dutch biotech VarmX will use the proceedings of a €32M Series B to take a blood clotting protein drug into clinical trials by 2021, as well as strengthening its manufacturing and R&D capabilities. More than 10 million patients in the US and Europe at risk of blood clots and strokes receive blood thinners that […]

July 14, 2020 - 2 minutesmins - By Kostas Vavitsas

News and Trends 13 Jul 2020

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma giant Sanofi for up to €857.5M in a deal aiming to develop a combination immunotherapy for the blood cancer multiple myeloma. The preclinical-stage cell therapy that Kiadis licensed is based on genetically modifying donor immune cells called natural killer cells, […]

July 13, 2020 - 3 minutesmins - By David Wilson

News and Trends 13 Jul 2020

Forbion Raises €185M to Fuel Late-Stage European Biotechs

The Dutch life sciences venture capital firm Forbion has bagged €185M in the first closing of a fund aimed at investing in late-stage European biotech companies, which often struggle to raise capital. The main mission of Forbion’s fund — named the Growth Opportunities Fund — is to invest in European life sciences companies raising their […]

July 13, 2020 - 3 minutesmins - By David Wilson

In Depth 13 Jul 2020

The Three Obstacles Stopping Cell Therapy Becoming Mainstream

While there are now more cell therapies on offer than ever before, there are obstacles still preventing them from becoming widely used. Cell therapy holds enormous promise for treating many different diseases. However, the field has also seen controversy regarding therapies using embryonic stem cells, as well as problematic fraud cases. Some forms of cell […]

July 13, 2020 - 9 minutesmins - By Helen Albert

News and Trends 10 Jul 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

Stockholm and Copenhagen-based Eir Ventures has announced the closure of its first fund at €76M, which will be used to invest in biotechs and other life science companies, with a focus on the Nordics. The fund is backed by Saminvest, a venture capital company founded by the Swedish Government; Vækstfonden, the Danish state’s investment fund; […]

July 10, 2020 - 3 minutesmins - By Laura Cowen

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Artificial Intelligence: A Superpower in the Fight Against Covid-19

Global €870M Fund Launched to Address Antimicrobial Resistance

Russian Hackers Launch Cyber Attack on Covid-19 Vaccine Developers

Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment

Danish Wound Healing Biotech Raises €20M to Accelerate US Rollout

European Biotech Stocks Shine Amid 2020 Market Slump

Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments

€32M Series B to Fund Bleeding Medication Inspired by Snake Venom

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

Forbion Raises €185M to Fuel Late-Stage European Biotechs

The Three Obstacles Stopping Cell Therapy Becoming Mainstream

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!